Using an innovative new imaging technique, researchers at Weill Cornell Medicine have revealed the inner workings of a family of light-sensing molecules in unprecedented detail and speed.
Cornell's Office of Academic Integration has announced 15 new multi-investigator seed grants, including support for a project on climate change, pollen and asthma attacks and another to develop a microbial delivery system for a unique treatment of colorectal cancer.
Cornell researchers have for the first time imaged the entire depth of the lymph nodes in a living mouse using three-photon microscopy, which enabled them to observe the dynamic interactions of immune cells.
By mapping all the protein interactions of a dementia-linked protein in the brain called Tau, a team of Weill Cornell Medicine investigators has created a road map for identifying potential new treatment targets for Alzheimer’s disease and related dementia.
Researchers at Weill Cornell Medicine have developed a pre-clinical model of the leading cause of central vision loss in older individuals, dry age-related macular degeneration, and used it to identify new treatment modalities and drug targets.
The Division of Nutritional Sciences and partner RTI International won a five-year, $23 million award to coordinate research for the NIH’s Nutrition for Precision Health study.
A study also revealed that expanded duties, particularly emotional care, resulted in a higher perceived value of the workers’ contributions, which could help boost pay for home care workers.
Professors Neil Lewis Jr. ’13 and Tashara Leak are leading the new Action Research Collaborative, which will serve as an institutional hub for cross-campus action research collaborations between Ithaca and New York City, and elsewhere.
While the world has celebrated the arrival of highly effective vaccines against COVID-19, new work by researchers at Weill Cornell Medicine and the University of Oxford shows that even unrelated vaccines could help reduce the burden of the pandemic.
